期刊文献+

抗青光眼药的使用及其副作用 被引量:13

Effect and toxicity of antiglaucoma solutions
下载PDF
导出
摘要 抗青光眼药种类繁多,其用法、效果以及各自的毒副作用都不相同,在临床工作中,要做到合理有效使用每种药物并且避免毒副作用。本文总结了近年来关于抗青光眼药物的作用机制和不良反应的文章,概述抗青光眼药引起的眼部非特异性炎症,分别总结了各类药物的作用机制和毒副作用,最后总结了国外关于联合用药的原则和不良反应。以期在临床工作中有所帮助。 There are sorts of antiglaucoma drops which have different work mechanisms and clinical effect. Meanwhile, ocular surface toxicity caused by the abuse of these eye drops was common in patients receiving antiglaucoma treatment for a long time. This article reviews drug action of antiglaucoma drops, effect of preservative and combination of ophthalmo logic solutions in recent published reports. It is advisable to master all these information as a clinical oculist,and it is helpful to our clinical work.
作者 张婧 卢艳
出处 《眼科新进展》 CAS 2007年第9期707-710,共4页 Recent Advances in Ophthalmology
关键词 青光眼 眼液 作用机制 毒性 防腐剂 联合用药 glaucoma ophthalmic solutions drugaction drug toxicity preservatives combination
  • 相关文献

参考文献31

  • 1Mietz H,Niesen U,Krieglstein GK. The effects of preservatives and antiglaucomatous medication on histopathology of the conjunctiva[ J]. Mietz Graefe Arch Clin Exp Ophthalmol 1994 ;232:561-565.
  • 2Broadway DC, Grierson I, O' Brien C, Hitchings RA. Adverse effects of topical antiglaucomatous medications, II : the outcome of filtration surgery [ J]. Arch Ophthalmol 1994 ; 112 : 1446-1454.
  • 3Eleftheriadis H, Cheong M, Sandeman S. Corneal toxicity secondary to inadvertent use of benzalkontum chloride preserved viscoelastic material in cataract surgery[ J ]. Br J Oph thalmol 2002 ; 86 : 299-305.
  • 4Miyake K, Ibaraki N,Goto Y. ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy [ J ]. J Cataract Refract Surg 2003 ;29 : 1800-1810.
  • 5Herbst RA, Uter W,Pirker C,Findlay C. Allergic and nonallergic periorbital dermatitis:patch test results of the information network of the departments of dermatology during a 5-year period [ J ]. CODEDG (Contact Dermatitis )2004;51:13-19.
  • 6Pisella PJ, Pouliquen P, Baudouin C. Prevalence of octtlar symptoms and signs with preserved and preservative free glaucoma medication [ J ]. Br J Oph t halmol 2002;86:418.
  • 7Guenoun JM,Baudottin C,Rat P,Pauly A,Warnet JM,Brignole BF. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells[ J]. Invest Ophthalmol Vis Sci 2005 ;46(7) :2444-2450.
  • 8Catherine PH,Debbasch B,Warnet JM,Baudouin C, Brignole F. In vitro effects of preservedand tmpreserved antiglaucoma drugson apoptotic marker expression by httman trabecttlar cells [ J]. Graefe Arch Clin Exp Ophthalmol 2003 ;241 : 1037-1043.
  • 9Lee DA, Higginbotham EJ. glaucoma and its treatment[ J]. Am J Health Syst Pharrn 2005 ;62 (7) :691-699.
  • 10Dong Y,Ishikawa H,Wu Y, Shtmizu K, Goseki T,Yoshitomi T. Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery[J]. Jpn J Ophthalmol 2006 ;50:504-508.

二级参考文献10

共引文献5

同被引文献152

引证文献13

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部